Annual Drug Patent Expirations for TOVIAZ
Toviaz is a drug marketed by Pfizer and is included in one NDA. It is available from two suppliers. There are four patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for TOVIAZ.
The generic ingredient in TOVIAZ is fesoterodine fumarate. Two suppliers are listed for this compound. Additional details are available on the fesoterodine fumarate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
